SCHEMBL5380880

SCHEMBL5380880

[CH2]CCCCCN1CCCCC1

nearest known ligand 0.75

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.75
SIGMAR1 Q99720 2/20 0.47
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CXCR4 P61073 1/20 0.43
ALDH1A1 P00352 2/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10709367 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL11280188 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL5395587 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL5392834 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL5385522 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL11460076 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL6715590 1.00 HRH3 (0.75) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL2091529 0.97 HRH3 (0.70) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL5388937 0.97 HRH3 (0.70) HRH3SIGMAR1MAPTCYP1A2MAPK1
SCHEMBL6716650 0.97 HRH3 (0.70) HRH3SIGMAR1MAPTCYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024022953-A1 A PROCESS FOR PRODUCING A TEA PRODUCT Ekaterra Research and Development UK Limited (GB) 2024-02-01 WO disclosed
EP-4311435-A1 A PROCESS FOR PRODUCING A TEA PRODUCT Ekaterra Research and Development UK Limited (GB) 2024-01-31 EP disclosed
CN-109702008-A Method for strengthening electrokinetic remediation of arsenic-chromium composite contaminated soil by reducing agent/chelating agent 上海大学 2019-05-03 CN disclosed
CN-102781973-B Comprise functionalization multiarm polymers and their application of the functionalized polymeric synthesized by anionic polymerisation 戴纳索尔埃拉斯托默罗斯有限公司 2016-10-19 CN disclosed
CN-102532162-B 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMA CO LTD 2015-05-27 CN disclosed
US-8461375-B2 Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling EVONIK RÖHM GMBH (DE) 2013-06-11 US disclosed
EP-1583733-B1 IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING EVONIK ROEHM GMBH (DE) 2013-04-24 EP disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
CN-102781973-A Functionalised multiarm polymers comprising functionalised polymers synthesised through anionic polymerisation and applications thereof DYNASOL ELASTOMEROS SA 2012-11-14 CN disclosed
WO-2002100814-A1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF AKTIENGESELLSCHAFT (DE) 2002-12-19 WO disclosed
WO-2002090566-A2 RECOMBINANT TUMOR SPECIFIC ANTIBODY AND USE THEREOF MERCK PATENT GMBH (DE) 2002-11-14 WO disclosed
US-5488140-A ANTICONVULSANTS CIBA-GEIGY CORPORATION (US) 1996-01-30 US disclosed
EP-0420806-B1 Phosphonic acids, process for preparation and use as an active pharmaceutical composition CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
US-5294734-A 1-phosphato-4-amino-pent-2-enoic acids and derivatives CIBA-GEIGY CORP. (US) 1994-03-15 US disclosed
EP-0215435-B1 2-OXA-ISOCEPHEM COMPOUNDS, COMPOSITIONS CONTAINING SAME AND PROCESSES FOR PREPARING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP disclosed
US-5026728-A Immune modulators FOODSCIENCE CORPORATION (US) 1991-06-25 US disclosed
EP-0420806-A1 Phosphonic acids, process for preparation and use as an active pharmaceutical composition CIBA-GEIGY AG (CH) 1991-04-03 EP disclosed
US-4831026-A ANTIBIOTICS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
EP-0215435-A1 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-03-25 EP disclosed